Showing results (11-20 of 131) with videos related to
Sort By:
Pageof 14
Urology|February 27, 2007
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 yearsNelson N Stone, Richard G StockThe Journal of Urology|April 5, 2014
15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapyNelson N Stone, Richard G StockJournal of Neuro-Oncology|July 1, 2010
Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. StatesSteven Lehrer, Sheryl Green, Richard G StockInternational Journal of Radiation Oncology, Biology, Physics|October 8, 2003
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant qualityMarisa A Kollmeier, Richard G Stock, Nelson StoneThe Journal of Urology|December 14, 2004
Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapySteven Lehrer, Nelson N Stone, Richard G StockThe Journal of Urology|February 16, 2005
Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancerNelson N Stone, Richard G Stock, Pam UngerBrachytherapy|March 29, 2020
Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiationNelson N Stone, Vassilios Skouteris, Richard G StockInternational Journal of Radiation Oncology, Biology, Physics|November 22, 2011
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancerKevin Forsythe, Seth Blacksburg, Nelson Stone, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2011
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failureEric C Ko, Nelson N Stone, Richard G StockBrachytherapy|February 7, 2012
Biopsy and implantation of the seminal vesiclesNelson N Stone, Vassilios M Skouteris, Richard G StockPageof 14